Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Pain 2Breast Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Neuroma 1Lower Urinary Tract Symptoms 1Low Anterior Resection Syndrome 1Hereditary leiomyomatosis and renal cell cancer 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Chronic Pain 1Carcinoma, Renal Cell 1Agnosia 1

Interventions

Morphine 6Analgesia 6nabiximols 3Pregabalin 3Oxycodone 3Fentanyl 3ziconotide 2Surveys and Questionnaires 2Saline Solution 2Radiofrequency Ablation 2Methadone 2Lidocaine 2Ketamine 2Ibandronic Acid 2Gemcitabine 2Duloxetine Hydrochloride 2Docetaxel 2Botulinum Toxins, Type A 2trimebutine 3-thiocarbamoylbenzenesulfonate 1tanezumab 1tandutinib 1siltuximab 1resiniferatoxin 1incobotulinumtoxinA 1imisopasem manganese 1fulranumab 1erenumab 1cyclobenzaprine 1caffeine, sodium benzoate drug combination 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Pain × Botulinum Toxins, Type A × Clear all
NCT02044302 2017-04-10

A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction

Yale University

Phase 2 Terminated
2 enrolled 3 charts
Breast

Breast Neoplasms, Pain, Pain, Postoperative

NCT01374191 2015-08-26

Botulinum Toxin Type A for Neuroma Pain

Southern Illinois University

Phase 2 Withdrawn

Neuroma, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡